Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - OTHER FINANCING ACTIVITIES
Other Financing Activities ALNY - Alnylam Pharmaceuticals, Inc.
294 M
LAST VALUE
30.87%
2 YEAR CAGR
48.10%
5 YEAR CAGR
25.89%
10 YEAR CAGR